T1	PROC 46 73	Tratamiento antirretroviral
#1	AnnotatorNotes T1	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T2	CHEM 58 73	antirretroviral
#2	AnnotatorNotes T2	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T3	ANAT 871 874	cel
#3	AnnotatorNotes T3	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T4	PROC 125 152	Tratamiento antirretroviral
#4	AnnotatorNotes T4	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T5	CHEM 137 152	antirretroviral
#5	AnnotatorNotes T5	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T6	PROC 183 226	ensayo clínico piloto de prueba de concepto
T7	DISO 353 372	infectado por VIH-1
T8	PROC 407 434	tratamiento antirretroviral
#6	AnnotatorNotes T8	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T9	PROC 949 985	consentimiento informado por escrito
#7	AnnotatorNotes T9	C0811741; Obtain informed written consent; Health Care Activity
T10	PROC 472 483	Tratamiento
#8	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	CHEM 507 510	3TC
#9	AnnotatorNotes T11	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T12	PROC 530 567	cambio de tratamiento antirretroviral
#10	AnnotatorNotes T12	C2919691; Treatment changed; Health Care Activity + C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T13	PROC 846 865	Nivel actual de CD4
#11	AnnotatorNotes T13	C0243009; CD4 Count determination procedure; Laboratory Procedure (?)
T14	ANAT 862 865	CD4
#12	AnnotatorNotes T14	C0039215; CD4 Positive T Lymphocytes; Cell
T15	CHEM 890 917	inhibidores de la integrasa
#13	AnnotatorNotes T15	C0376601; Integrase Inhibitors; Biologically Active Substance · Pharmacologic Substance
T16	DISO 1191 1201	mutaciones
#14	AnnotatorNotes T16	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T17	PROC 1078 1090	pauta de TAR
T18	CHEM 1111 1114	FTC
#15	AnnotatorNotes T18	C0909839; emtricitabine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T19	CHEM 1105 1108	3TC
#16	AnnotatorNotes T19	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T20	DISO 1376 1386	mutaciones
#17	AnnotatorNotes T20	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T21	PROC 1310 1322	pauta de TAR
T22	CHEM 1343 1346	FTC
#18	AnnotatorNotes T22	C0909839; emtricitabine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T23	CHEM 1337 1340	3TC
#19	AnnotatorNotes T23	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T24	PROC 1436 1445	Detección
#20	AnnotatorNotes T24	C1511790; Detection; Therapeutic or Preventive Procedure
T25	CHEM 1488 1500	ADN proviral
#21	AnnotatorNotes T25	C4034198; HIV proviral DNA; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T26	DISO 577 589	intolerancia
#22	AnnotatorNotes T26	C0277585; Intolerance to drug; Pathologic Function
T27	ANAT 1504 1521	sangre periférica
#23	AnnotatorNotes T27	C0229664; peripheral blood; Body Substance
T28	PROC 1531 1544	secuenciación
#24	AnnotatorNotes T28	C0162801; Sequence Analysis; Molecular Biology Research Technique
T29	PROC 1666 1687	método anticonceptivo
#25	AnnotatorNotes T29	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T30	CHEM 513 516	FTC
#26	AnnotatorNotes T30	C0909839; emtricitabine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T31	DISO 251 254	VIH
#27	AnnotatorNotes T31	C0458074; Human immunodeficiency virus (HIV) status; Finding
T32	DISO 281 314	Virus de Inmunodeficiencia Humana
#28	AnnotatorNotes T32	C0458074; Human immunodeficiency virus (HIV) status; Finding
T33	CHEM 419 434	antirretroviral
#29	AnnotatorNotes T33	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T34	CHEM 552 567	antirretroviral
#30	AnnotatorNotes T34	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T35	PROC 625 636	Carga viral
#31	AnnotatorNotes T35	C1261478; Viral load measurement; Laboratory Procedure
T36	DISO 1474 1484	mutaciones
#32	AnnotatorNotes T36	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T37	Date 13 17	2017
T38	PROC 85 93	genotipo
#33	AnnotatorNotes T38	C1285573; Genotype determination; Laboratory Procedure
T39	PROC 164 172	genotipo
#34	AnnotatorNotes T39	C1285573; Genotype determination; Laboratory Procedure
T42	LIVB 344 352	Paciente
#35	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Age 382 391	> 18 años
T44	Duration 451 467	al menos 3 meses
T45	Date 484 490	actual
T46	Duration 674 688	al menos 1 año
T47	Duration 735 749	los tres meses
T48	Date 852 858	actual
T49	LIVB 1028 1037	pacientes
#36	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T53	Neg_cue 1183 1186	sin
T54	LIVB 1263 1272	pacientes
#37	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	PROC 1349 1357	genotipo
#38	AnnotatorNotes T55	C1285573; Genotype determination; Laboratory Procedure
T56	LIVB 1582 1601	Mujeres embarazadas
#39	AnnotatorNotes T56	C0033011; Pregnant Women; Population Group
T57	LIVB 1603 1612	lactantes
#40	AnnotatorNotes T57	C4316174; Patients who are breastfeeding; Patient or Disabled Group
T58	Age 1618 1629	edad fértil
T59	PHYS 1590 1601	embarazadas
#41	AnnotatorNotes T59	C0032961; Pregnancy; Organism Function
T60	Neg_cue 1634 1636	no
T61	LIVB 631 636	viral
#42	AnnotatorNotes T61	C0042776; Virus; Virus
T40	LIVB 367 372	VIH-1
#43	AnnotatorNotes T40	C0019704; HIV-1; Virus
T41	PHYS 931 939	entender
#44	AnnotatorNotes T41	C0162340; Comprehension; Mental Process
T50	PROC 1162 1170	genotipo
#45	AnnotatorNotes T50	C1285573; Genotype determination; Laboratory Procedure
T51	Neg_cue 882 889	Naïve a
A1	Status T15 History_of
A2	Assertion T15 Negated
A3	Assertion T16 Negated
A4	Assertion T29 Negated
A5	Status T10 History_of
A6	Status T11 History_of
A7	Status T30 History_of
#46	AnnotatorNotes T6	C0031928; Pilot Projects; Research Activity + C4505280; Proof of Concept Study; Research Activity 
#47	AnnotatorNotes T7	C2363741; HIV-1 infection; Disease or Syndrome
#48	AnnotatorNotes T45	C0521116; Current (present time); Temporal Concept 
#49	AnnotatorNotes T48	C0521116; Current (present time); Temporal Concept 
T52	Observation 1055 1073	fracaso virológico
A8	Status T52 History_of
A9	Assertion T52 Negated
T62	Neg_cue 1040 1042	no
R1	Negation Arg1:T51 Arg2:T15	
R2	Negation Arg1:T62 Arg2:T52	
R3	Negation Arg1:T53 Arg2:T16	
T63	Quantifier_or_Qualifier 1202 1209	M184V/I
A10	Assertion T63 Negated
T64	Quantifier_or_Qualifier 1212 1220	K65R/E/N
A11	Assertion T64 Negated
R4	Negation Arg1:T53 Arg2:T64	
R5	Negation Arg1:T53 Arg2:T63	
R6	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T63	
R7	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T64	
T65	Quantifier_or_Qualifier 1387 1394	M184V/I
R8	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T65	
T66	Quantifier_or_Qualifier 1397 1405	K65R/E/N
R9	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T66	
T67	Quantifier_or_Qualifier 1559 1566	M184V/I
T68	Quantifier_or_Qualifier 1569 1577	K65R/E/N
R10	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T67	
R11	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T68	
R12	Negation Arg1:T60 Arg2:T29	
T69	Observation 1287 1305	fracaso virológico
#50	AnnotatorNotes T69	C4053865; Virologic Non-Response; Finding (?)
R13	Overlap Arg1:T69 Arg2:T21	
R14	Used_for Arg1:T23 Arg2:T21	
R15	Used_for Arg1:T22 Arg2:T21	
T70	Observation 1139 1146	fracaso
#51	AnnotatorNotes T70	C4053865; Virologic Non-Response; Finding (?)
#52	AnnotatorNotes T52	C4053865; Virologic Non-Response; Finding (?)
A12	Status T69 History_of
R16	Used_for Arg1:T2 Arg2:T1	
R17	Before Arg1:T38 Arg2:T1	
R18	Before Arg1:T39 Arg2:T4	
R19	Used_for Arg1:T5 Arg2:T4	
T71	Quantifier_or_Qualifier 94 102	proviral
R20	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T71	
T72	Quantifier_or_Qualifier 173 181	proviral
R21	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T72	
R22	Causes Arg1:T40 Arg2:T7	
R23	Experiences Arg1:T42 Arg2:T7	
R24	Used_for Arg1:T33 Arg2:T8	
R25	Has_Duration_or_Interval Arg1:T33 Arg2:T44	
T73	Quantifier_or_Qualifier 435 442	estable
#53	AnnotatorNotes T73	C0205360; Stable status; Qualitative Concept
R26	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T73	
R27	Overlap Arg1:T11 Arg2:T45	
R28	Overlap Arg1:T30 Arg2:T45	
R29	Used_for Arg1:T11 Arg2:T10	
R30	Used_for Arg1:T30 Arg2:T10	
T74	Observation 521 526	Deseo
#54	AnnotatorNotes T74	C0600109; Willing; Finding
R31	Overlap Arg1:T74 Arg2:T12	
R32	Used_for Arg1:T34 Arg2:T12	
R33	Causes Arg1:T34 Arg2:T26	
T75	Result_or_Value 651 661	<50 cop/mL
R34	Has_Duration_or_Interval Arg1:T35 Arg2:T46	
R35	Has_Result_or_Value Arg1:T35 Arg2:T75	
T76	Result_or_Value 637 649	indetectable
#55	AnnotatorNotes T76	C3827727; Undetectable; Clinical Attribute
R36	Has_Result_or_Value Arg1:T35 Arg2:T76	
T77	Result_or_Value 701 708	un blip
T78	Result_or_Value 710 724	≤500 copias/mL
T79	CONC 763 772	inclusión
#56	AnnotatorNotes T79	C1512693; Inclusion; Qualitative Concept
R37	Before Arg1:T77 Arg2:T79	
R38	Before Arg1:T78 Arg2:T79	
R39	Before Arg1:T77 Arg2:T47	
R40	Before Arg1:T78 Arg2:T47	
T80	Result_or_Value 829 841	indetectable
#57	AnnotatorNotes T80	C3827727; Undetectable; Clinical Attribute
R41	Before Arg1:T80 Arg2:T77	
R42	After Arg1:T80 Arg2:T77	
R43	Before Arg1:T80 Arg2:T78	
R44	After Arg1:T80 Arg2:T78	
T81	Result_or_Value 866 877	>350 cel/µL
R45	Has_Result_or_Value Arg1:T13 Arg2:T81	
R46	Overlap Arg1:T13 Arg2:T48	
R47	Overlap Arg1:T41 Arg2:T9	
T82	Observation 922 927	Capaz
#58	AnnotatorNotes T82	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R48	Overlap Arg1:T82 Arg2:T41	
R49	Overlap Arg1:T82 Arg2:T9	
R50	Experiences Arg1:T49 Arg2:T52	
R51	Experiences Arg1:T49 Arg2:T17	
#59	AnnotatorNotes T21	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure (?)
#60	AnnotatorNotes T17	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure (?)
R52	Used_for Arg1:T19 Arg2:T17	
R53	Used_for Arg1:T18 Arg2:T17	
R54	Experiences Arg1:T49 Arg2:T70	
R55	Overlap Arg1:T70 Arg2:T50	
R57	Experiences Arg1:T49 Arg2:T50	
R58	Experiences Arg1:T49 Arg2:T16	
R59	Overlap Arg1:T52 Arg2:T17	
R60	Experiences Arg1:T54 Arg2:T69	
R61	Experiences Arg1:T54 Arg2:T21	
R62	Experiences Arg1:T54 Arg2:T55	
R63	Experiences Arg1:T54 Arg2:T20	
A13	Status T55 History_of
R65	Before Arg1:T55 Arg2:T21	
R66	Before Arg1:T55 Arg2:T69	
R68	Location_of Arg1:T27 Arg2:T36	
R69	Before Arg1:T28 Arg2:T24	
R71	Location_of Arg1:T25 Arg2:T36	
R72	Experiences Arg1:T56 Arg2:T59	
R73	Overlap Arg1:T29 Arg2:T58	
T83	Quantifier_or_Qualifier 1688 1696	adecuado
A14	Assertion T83 Negated
#61	AnnotatorNotes T83	C0205411; Adequate; Qualitative Concept
R74	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T83	
R75	Negation Arg1:T60 Arg2:T83	
R76	Before Arg1:T79 Arg2:T80	
R77	After Arg1:T79 Arg2:T80	
R78	Experiences Arg1:T49 Arg2:T19	
R79	Experiences Arg1:T49 Arg2:T18	
R80	Experiences Arg1:T54 Arg2:T23	
R81	Experiences Arg1:T54 Arg2:T22	
A15	Experiencer T42 Patient
A16	Experiencer T49 Patient
A17	Experiencer T54 Patient
A18	Experiencer T56 Patient
A19	Experiencer T57 Patient
